196 filings
Page 4 of 10
8-K
rebhu3 hejci0e8ke
28 Nov 18
Other Events
4:28pm
8-K
egnxj 1v2
21 Nov 18
Entry into a Material Definitive Agreement
4:00pm
8-K
ml4qe1
8 Nov 18
Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019
4:03pm
8-K
mi8rhe6lw 2x12e62x0
4 Oct 18
Departure of Directors or Certain Officers
4:14pm
8-K
hnw97cnzci
19 Sep 18
Departure of Directors or Certain Officers
4:28pm
8-K
hmxpepuqkp
13 Sep 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
1nyfr3ys
8 Aug 18
Sonoma Pharmaceuticals Reports First Quarter FY 2019 Financial Results
12:00am
8-K
9y2w7rn
13 Jun 18
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2018 Financial Results
12:00am
8-K
kwp3hr5n152bnjf7e
5 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
w0ajn yvb0tf4lh
6 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
rky53xn1zlqye
7 Feb 18
Results of Operations and Financial Condition
12:00am
8-K
43wngl9
8 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
wht1c9ijhuy6l
9 Nov 17
Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million
12:00am
8-K
vf3upam
1 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
u6ri ecbkdfn9kogwa
11 Sep 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
xkvzeynb
8 Aug 17
Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018
12:00am
8-K
l6dyj8j3aq4f0pceg
5 Jun 17
Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017
12:00am
8-K
w7fj3f98 lmle1
7 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
zh4s go0u5lwzijfbcm
9 Feb 17
Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017
12:00am
8-K
2is1f sq1sm7r6veye
23 Jan 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am